Joel Greenblatt's WST Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 1,742 shares of West Pharmaceutical Services, Inc. (WST) worth $479,294, representing 0.00% of the portfolio. First purchased in 2013-Q4, this long-term strategic position has been held for 32 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in WST, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2019, adding 23,441 shares. Largest reduction occurred in Q3 2019, reducing 25,185 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's West Pharmaceutical Services (WST) Holding Value Over Time
Track share changes against reported price movement
Quarterly West Pharmaceutical Services (WST) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +1,742 | New Buy | 1,742 | $275.14 |
| Q2 2025 | -2,090 | Sold Out | 0 | $0.00 |
| Q1 2025 | -72 | Reduce 3.33% | 2,090 | $223.88 |
| Q3 2024 | +53 | Add 2.51% | 2,162 | $300.16 |
| Q2 2024 | +7 | Add 0.33% | 2,109 | $329.39 |
| Q1 2024 | -5,522 | Reduce 72.43% | 2,102 | $395.71 |
| Q4 2023 | -3,594 | Reduce 32.04% | 7,624 | $352.12 |
| Q3 2023 | -835 | Reduce 6.93% | 11,218 | $375.21 |
| Q2 2023 | -787 | Reduce 6.13% | 12,053 | $382.47 |
| Q1 2023 | -4,859 | Reduce 27.45% | 12,840 | $346.47 |
| Q4 2022 | -1,901 | Reduce 9.70% | 17,699 | $235.35 |
| Q3 2022 | +17,011 | Add 657.05% | 19,600 | $246.07 |
| Q2 2022 | -854 | Reduce 24.80% | 2,589 | $302.43 |
| Q1 2022 | +2,183 | Add 173.25% | 3,443 | $410.69 |
| Q4 2021 | +608 | Add 93.25% | 1,260 | $469.05 |
| Q3 2021 | -73 | Reduce 10.07% | 652 | $424.85 |
| Q2 2021 | -4,577 | Reduce 86.33% | 725 | $358.62 |
| Q1 2021 | -5,489 | Reduce 50.87% | 5,302 | $281.78 |
| Q4 2020 | -6,603 | Reduce 37.96% | 10,791 | $283.29 |
| Q3 2020 | +1,391 | Add 8.69% | 17,394 | $274.92 |
| Q2 2020 | +12,317 | Add 334.16% | 16,003 | $227.14 |
| Q1 2020 | -18,715 | Reduce 83.55% | 3,686 | $152.20 |
| Q4 2019 | +13,860 | Add 162.28% | 22,401 | $150.35 |
| Q3 2019 | -25,185 | Reduce 74.68% | 8,541 | $141.79 |
| Q2 2019 | +23,441 | Add 227.91% | 33,726 | $125.16 |
| Q1 2019 | -13,191 | Reduce 56.19% | 10,285 | $110.16 |
| Q4 2018 | +5,675 | Add 31.88% | 23,476 | $98.01 |
| Q3 2018 | +17,801 | New Buy | 17,801 | $123.48 |
| Q2 2014 | -5,132 | Sold Out | 0 | $0.00 |
| Q1 2014 | -859 | Reduce 14.34% | 5,132 | $44.04 |
| Q4 2013 | +5,991 | New Buy | 5,991 | $49.07 |
Joel Greenblatt's West Pharmaceutical Services Investment FAQs
Joel Greenblatt first purchased West Pharmaceutical Services, Inc. (WST) in Q4 2013, acquiring 5,991 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held West Pharmaceutical Services, Inc. (WST) for 32 quarters since Q4 2013.
Joel Greenblatt's largest addition to West Pharmaceutical Services, Inc. (WST) was in Q2 2019, adding 33,726 shares worth $4.22 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 1,742 shares of West Pharmaceutical Services, Inc. (WST), valued at approximately $479,294.
As of the Q4 2025 filing, West Pharmaceutical Services, Inc. (WST) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in West Pharmaceutical Services, Inc. (WST) was 33,726 shares, as reported at the end of Q2 2019.